Inventor · disambiguated record
Michael Cannarile
Also filed as: CANNARILE MICHAEL
2 granted patents·5 pending applications·2 citations·filing 2013–2023
37Inventor score
Top patents by PatentIndex Score
7 records- 0169US11498968B2Treatment of tumors with an anti-CSF-1R antibody in combination with an anti-PD-L1 antibody after failure of anti-PD-L1/PD1 treatmentHOFFMANN LA ROCHE·Filed 2019·Granted Nov 15, 2022·2 cites·12 claims
- 0261US2019185572A1Combination therapy of antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 0360US12454573B2Dosages of emactuzumabSYNOX THERAPEUTICS UK LTD·Filed 2022·Granted Oct 28, 2025·0 cites·5 claims
- 0455US2017247459A1Combination therapy of antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 0552US2015044232A1Markers for the responsiveness to anti-cd44 antibodiesHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 0652US2014079706A1Combination therapy of antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0752US2024094212A1Novel biomarkers and uses thereofHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Cannarile files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →